Polymer-Coated Microtiter Plate for Hydrophobic Drug Binding Assay
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods, such as equilibrium dialysis, are inadequate for measuring the binding coefficients of hydrophobic compounds to proteins or cellular components, as they are incompatible with the physico-chemical properties of these compounds.
Innovation Solution
A method using a 96-wells microtiter plate with varying polymer coatings and binding partner concentrations to determine protein binding coefficients of hydrophobic compounds through partition extraction, where the hydrophobic compound is extracted from the solution and its concentration in the polymer phase reflects its free concentration in solution, allowing for calculation of binding coefficients.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If equilibrium dialysis is used to measure binding coefficients, then measurement precision is improved for hydrophilic compounds, but the method becomes inapplicable for hydrophobic compounds due to incompatibility with their physico-chemical properties
Solution Approach 1:
The patent introduces a lipophilic polymer phase as an intermediary system to measure binding coefficients of hydrophobic compounds. The polymer-coated microtiter plate creates a lipophilic environment that mediates the interaction between hydrophobic drugs and plasma proteins, allowing equilibrium to be established and measured in a manner compatible with hydrophobic compound properties.
Solution Approach 2:
The patent changes the physical-chemical parameters of the assay system by introducing a lipophilic polymer coating on the microtiter plate surface. This parameter change creates a favorable environment for hydrophobic compounds, altering the assay conditions from aqueous-based equilibrium dialysis to a lipophilic-aqueous interface system that accommodates hydrophobic drug characteristics.
2Adaptability or versatility
If special techniques are employed for equilibrium dialysis to measure hydrophobic drug binding, then measurement capability is improved, but device complexity and procedural difficulty increase
Solution Approach 1:
The patent employs disposable microtiter plates with pre-coated lipophilic polymer surfaces, replacing complex reusable equilibrium dialysis apparatus with simple, single-use plates. This eliminates the need for complex cleaning, sterilization, and calibration procedures associated with traditional dialysis devices while maintaining measurement capability for hydrophobic compounds.
Solution Approach 2:
The patent replaces the mechanical dialysis system (requiring dialysis membranes, chambers, and fluid handling) with a simplified partition-based system using lipophilic polymer-coated microtiter plates. The measurement relies on thermodynamic partitioning rather than mechanical dialysis, reducing device complexity while enabling hydrophobic compound analysis.
3Ease of manufacture
If conventional equilibrium dialysis is used, then established methodology is maintained, but simplicity and reliability are reduced for hydrophobic compound analysis
Solution Approach 1:
The patent segments the assay system into distinct lipophilic (polymer coating) and aqueous (plasma solution) phases within microtiter plate wells. This segmentation creates a defined interface that reliably accommodates hydrophobic compounds, improving measurement reliability while maintaining procedural simplicity through standardized plate formats.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a simple and reliable way to measure the binding coefficients of hydrophobic compounds to proteins or cellular components, enabling efficient prediction of drug behavior and dose-effect relationships, particularly for hydrophobic compounds that are challenging with existing technologies.
Implementation Method 1
The actual measurement is preferably performed in a simple, standard 96-wells microtiter plate... wherein the hydrophobic compound is extracted from the solution and its concentration in the polymer phase reflects its free concentration in solution
Data Source
AI summary
The invention comprises a method for the determination of the binding coefficient of a hydrophobic chemical compound comprising: g. Providing an assay plate with a plurality of rows and columns of test vessels; h. Providing the majority of the test vessels in said assay plate with a polymer, wherein in each row the amount of polymer coating per test vessel is increased; i. Filling each test vessel with a solution of binding partner to which the binding coefficient should be assayed, wherein in each column the amount of binding partner is increased; j. Adding the hydrophobic compound and incubate the plate; k. Determining the concentration of said compound in said polymer or in the solution; l. Calculating the protein binding coefficient of the compound.